Found: 29
Select item for more details and to access through your institution.
Editorial: determinants of diagnostic delay in autoimmune atrophic gastritis–a salutary lesson. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 459, doi. 10.1111/apt.15415
- By:
- Publication type:
- Article
Reply letter to "Editorial: bodybuilders beware".
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 473, doi. 10.1111/apt.15400
- By:
- Publication type:
- Article
No increased risk of nephrotoxicity associated with 5‐aminosalicylic acid in IBD: a population‐based cohort and nested case‐control study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 416, doi. 10.1111/apt.15408
- By:
- Publication type:
- Article
Editorial: the overlap between dyspepsia and gastro‐oesophageal reflux—is duodenal eosinophilia the missing link? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 455, doi. 10.1111/apt.15406
- By:
- Publication type:
- Article
Real‐life study of safety of thiopurine‐allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 407, doi. 10.1111/apt.15402
- By:
- Publication type:
- Article
Editorial: biomarkers to optimise and personalise corticosteroid use among patients with severe alcoholic hepatitis—the search continues.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 462, doi. 10.1111/apt.15399
- By:
- Publication type:
- Article
Letter: when to withhold anti‐TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 465, doi. 10.1111/apt.15398
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: risk of new onset IBD with the use of anti‐interleukin‐17 agents.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 373, doi. 10.1111/apt.15397
- By:
- Publication type:
- Article
Editorial: determinants of diagnostic delay in autoimmune atrophic gastritis—a salutary lesson.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 458, doi. 10.1111/apt.15394
- By:
- Publication type:
- Article
Letter: immune checkpoint inhibitor‐induced colitis—shouldn't we be checking more often?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 472, doi. 10.1111/apt.15393
- By:
- Publication type:
- Article
Letter: pre‐operative anti‐TNF therapy in Crohn's disease is not associated with increased complications following elective surgery. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 469, doi. 10.1111/apt.15392
- By:
- Publication type:
- Article
Letter: clinical outcomes after long‐term entecavir or tenofovir treatment in patients with hepatitis D and advanced fibrosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 471, doi. 10.1111/apt.15367
- By:
- Publication type:
- Article
Editorial: the overlap between dyspepsia and gastro‐oesophageal reflux—is duodenal eosinophilia the missing link?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 454, doi. 10.1111/apt.15388
- By:
- Publication type:
- Article
Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 397, doi. 10.1111/apt.15386
- By:
- Publication type:
- Article
Letter: when to withhold anti‐TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 464, doi. 10.1111/apt.15384
- By:
- Publication type:
- Article
Letter: tenofovir disoproxil fumarate is safe for prevention of mother‐to‐child transmission of hepatitis B virus. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 477, doi. 10.1111/apt.15382
- By:
- Publication type:
- Article
Letter: improvement of clinical outcomes by metformin in metabolic liver disease—a microbiota‐dependent mechanism?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 474, doi. 10.1111/apt.15391
- By:
- Publication type:
- Article
Systematic review with meta‐analysis of over 90 000 patients. Does fast‐track review diagnose colorectal cancer earlier?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 348, doi. 10.1111/apt.15378
- By:
- Publication type:
- Article
Editorial: screening for oesophageal varices after directly acting anti‐viral therapy—do not let your guard down.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 461, doi. 10.1111/apt.15377
- By:
- Publication type:
- Article
Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 435, doi. 10.1111/apt.15326
- By:
- Publication type:
- Article
Earlier discontinuation of TNF‐α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 386, doi. 10.1111/apt.15380
- By:
- Publication type:
- Article
Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 442, doi. 10.1111/apt.15335
- By:
- Publication type:
- Article
Editorial: when cirrhosis deserves haemodialysis—rethinking strategies. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 457, doi. 10.1111/apt.15366
- By:
- Publication type:
- Article
Letter: pre‐operative anti‐TNF therapy in Crohn's disease is not associated with increased complications following elective surgery.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 467, doi. 10.1111/apt.15374
- By:
- Publication type:
- Article
Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005‐2016: a national database linkage study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 425, doi. 10.1111/apt.15320
- By:
- Publication type:
- Article
Editorial: when cirrhosis deserves haemodialysis—rethinking strategies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 456, doi. 10.1111/apt.15319
- By:
- Publication type:
- Article
Letter: tenofovir disoproxil fumarate is safe for prevention of mother‐to‐child transmission of hepatitis B virus.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 475, doi. 10.1111/apt.15305
- By:
- Publication type:
- Article
Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 478, doi. 10.1111/apt.15300
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 345, doi. 10.1111/apt.14883
- Publication type:
- Article